https://doi.org/10.4081/monaldi.2020.1224
Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose
Submitted: January 1, 2020
Accepted: February 4, 2020
Published: March 20, 2020
Accepted: February 4, 2020
Abstract Views: 1309
PDF: 793
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We present the case of a 80-year-old man with atrial fibrillation, morbid obesity (weight 123 kg, height 167 cm, BMI 44.1), high clearance of creatinine and pharmacological polytherapy, in which the serial determinations of edoxaban plasma levels help us to choose the appropriate dose.
How to Cite
Russo, Vincenzo, Anna Rago, Nunzia Laezza, Pierpaolo Di Micco, Laura Giannetti, Luigi Atripaldi, Antonio D’Onofrio, Paolo Golino, and Gerardo Nigro. 2020. “Edoxaban in Elderly Patient With Morbid Obesity and Atrial Fibrillation: The Role of Plasma Levels Evaluation for Selecting the Appropriate Dose”. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1224.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Angelica Cersosimo, Mauro Riccardi, Ludovica Amore, Giuliana Cimino, Gianmarco Arabia, Marco Metra, Enrico Vizzardi, Varicella zoster virus and cardiovascular diseases , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Srishankar Bairy, Tarun Tiwari, Himanshu Mittal, Neeraj Gupta, Meghana M, Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect? , Monaldi Archives for Chest Disease: Early Access
- Vaishali Verma, Sachin Sondhi, Rajesh Sharma, Kunal Mahajan, COVID-19 associated viral myocarditis: does it exist? , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Ravindra Nath, Neeraj Kumar Gupta, Amandeep Jaswal, Sparsh Gupta, Navjot Kaur, Santvana Kohli, Anirudh saxena, Pranav Ish, Rohit Kumar, Poornima Tiwari, Mukesh Kumar, Jugal Kishore, Geeta Yadav, Fellisha Marwein, Nitesh Gupta, Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Raj Kumar, Parul Mrigpuri, Rohit Sarin, Jitendra Kumar Saini, Rashmi Yadav, Aditya Nagori, Sushil Kumar Kabra, Arpana Mukherjee, Geetika Yadav, Air pollution and its effects on emergency room visits in tertiary respiratory care centers in Delhi, India , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Paola Pierucci, Lucrezia De Michele, Maria Luisa de Candia, Federica Barratta, Cesare Gregoretti, Giovanna Elisiana Carpagnano, Giovanni Misseri, SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge , Monaldi Archives for Chest Disease: Early Access
You may also start an advanced similarity search for this article.
